One Equity Partners (OEP) has announced the exit from its investment in InfuCare Rx through a strategic founder-led equity buyback.
InfuCare, founded in 2014 and based in Fairfield, New Jersey, is a specialty infusion therapy services provider for patients with complex conditions.
OEP, founded in 2001 and based in New York, is a middle market private equity firm that targets investments in healthcare and a few other sectors. OEP seeks control-oriented investments with flexible structure in North American and Western Europeans companies with revenue between $100 million and $750 million and EBITDA of $10 million to $150 million.
Terms of the transaction were not disclosed.
